Sign in

or Register now

MyRACentral.com

See all of our health sites at www.HealthCentral.com
Friday, November 13, 2009
  • Font size
  • Bookmark
  • Save
Receive a FREE Osteoarthritis of the knee pamphlet.  Start here.

Drugmaker halts development of new RA drug

(Reuters) UPDATED 2008-10-09
Drugmaker Biogen has announced that it is halting development of a new rheumatoid arthritis (RA) medication. The drug, baminercept, failed to show that it was effective at treating RA in a mid-stage clinical trial. Biogen officials say they will continue to study the data on the drug and will present it at an upcoming scientific meeting.  Read full story >
See all Rheumatoid Arthritis News
  • Font size
  • Bookmark
  • Was this helpful? Yes
  • Save